Showing results (2331-2340 of 2,382) with videos related to

Sort By:
Pageof 239
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 1, 2021
Personalized Radiation Attenuating Materials for Gastrointestinal Mucosal ProtectionJames D Byrne, Cameron C Young, Jacqueline N Chu, et al.
Lancet (London, England)|July 27, 2020
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trialKenneth H Mayer, Jean-Michel Molina, Melanie A Thompson, et al.
Diabetes|October 27, 2004
Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locusDeborah Smyth, Jason D Cooper, Joanne E Collins, et al.
Science Advances|November 25, 2015
Co-infections determine patterns of mortality in a population exposed to parasite infectionMark E J Woolhouse, Samuel M Thumbi, Amy Jennings, et al.
Journal of Nephrology|May 29, 2024
Donor genetic burden for cerebrovascular risk and kidney transplant outcomeKane E Collins, Edmund Gilbert, Vincent Mauduit, et al.
Nature Communications|February 8, 2024
Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopmentRudrarup Bhattacharjee, Lachlan A Jolly, Mark A Corbett, et al.
Medrxiv : the Preprint Server for Health Sciences|January 18, 2024
A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disordersArthur S Lee, Lauren J Ayers, Michael Kosicki, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 19, 2025
Donor and Recipient Polygenic Risk Scores Influence Kidney Transplant FunctionKane E Collins, Edmund Gilbert, Vincent Mauduit, et al.
Nature Communications|September 27, 2024
A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disordersArthur S Lee, Lauren J Ayers, Michael Kosicki, et al.
The Lancet. HIV|August 29, 2025
Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trialPatrice Severe, Samuel Pierre, Fabienne Homeus, et al.
Pageof 239